7 KILLED, HUNDREDS INJURED AS STRONG QUAKE HITS SULAWESI, INDONESIA
VATICAN: POPE FRANCIS, FORMER POPE BENEDICT BOTH GET COVID-19 VACCINE
AUSTRALIA REBUKES GOOGLE FOR BLOCKING LOCAL CONTENT
JAPAN TO BAN ENTRY OF FOREIGN ATHLETES TO TRAIN AHEAD OF SUMMER OLYMPICS
BIDEN INAUGURATION WILL FEATURE DIVERSE PERFORMANCES INCLUDING LADY GAGA, JENNIFER LOPEZ
COURT ORDERS ARREST OF COPS ACCUSED OF KILLING ARMY MEN IN JOLO
THE PANDEMIC SLAMS PHL VEHICLE SALES IN 2020
CHESS PLAYER WESLEY SO BAGS P11.8M, JOINS WORLD’S TOP ESPORT EARNERS
ZSA ZSA PADILLA FINALLY VISITS THE GRAVE OF ‘COMEDY KING’ DOLPHY AGAIN
DUTERTE: PRESIDENCY JOB NOT FOR A WOMEN

COVID-19 VACCINE TRIAL VOLUNTEER HAD NEUROLOGICAL SYMPTOMS- ASTRAZENECA

7 months ago | World Science & Technology News | 0 comments

By Xai Reyes

AstraZeneca said a woman in the United Kingdom had symptoms consistent with a severe but rare spinal inflammatory disorder, which led to the British drugmaker’s decision to stop its clinical study of the new coronavirus vaccine.

According to Stat News, the participant was recovering and will likely be discharged from the hospital as early as today.

The new disclosures by Astra Chief Executive Pascal Soriot were shared by three of the investors participating in conference calls.

The London-listed firm said late Tuesday it would pause global trials of its COVID-19 vaccine candidate after an unexplained illness in a study participant.

0 Comments

Submit a Comment

Your email address will not be published.

Social Media